The future of saphenous vein as a coronary artery bypass conduit

Area of Science:

• Cardiovascular Surgery
• Vascular Biology
• Pharmacology

Background:

• Autologous saphenous vein grafts are widely used for coronary artery bypass grafting (CABG).
• Despite their common use, saphenous vein grafts exhibit suboptimal long-term patency rates.
• Platelet activation is implicated as a primary driver of early and late vein graft occlusion.

Purpose of the Study:

• To review the evidence linking platelet activation to vein graft occlusion.
• To identify key mechanisms contributing to early and late graft failure.
• To propose a comprehensive strategy for improving vein graft patency.

Main Methods:

• Literature review of studies investigating vein graft occlusion.
• Analysis of evidence implicating platelet activation in graft failure.
• Synthesis of findings to propose therapeutic interventions.

Main Results:

• Platelet activation is a significant factor in both early and late saphenous vein graft occlusion.
• Additional mechanisms, beyond platelet activation, likely contribute to late graft occlusions.
• The pathogenesis of vein graft occlusion shares similarities with coronary atherosclerosis.

Conclusions:

• Improving vein graft patency requires a multi-faceted approach.
• Key strategies include enhanced endothelial preservation during surgery.
• Utilizing advanced antiplatelet agents, managing risk factors like high cholesterol, and employing smooth muscle cell proliferation inhibitors (e.g., heparin) are crucial.
• Investigating vein graft patency may provide valuable insights into the broader process of atherogenesis.